相关实验视频

Updated: Jul 6, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.1K

一个基于深度学习的分类系统的病例控制临床试验,用于诊断粉样蛋白阳性阿尔茨海默病

Jong Bin Bae1,2, Subin Lee3, Hyunwoo Oh4

  • 1Department of Neuropsychiatry, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.

Psychiatry investigation
|January 1, 2024
PubMed
概括

一个深度学习系统使用脑MRI扫描准确地识别阿尔茨海默病 (AD). 这种人工智能工具显示出高灵敏度和特异性,有助于在临床环境中早期发现AD.

关键词:
阿尔茨海默氏症是阿尔茨海默氏症的疾病临床试验临床试验是指临床试验的临床试验.深度学习是一种深度学习.磁共振成像技术 磁共振成像技术

更多相关视频

Full- versus Sub-Regional Quantification of Amyloid-Beta Load on Mouse Brain Sections07:28

Full- versus Sub-Regional Quantification of Amyloid-Beta Load on Mouse Brain Sections

Published on: May 19, 2022

3.8K
Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images08:20

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images

Published on: October 27, 2023

1.5K

相关概念视频

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
491
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195